Update on emerging therapies for multiple sclerosis

Abstract

The American Academy of Neurology is an international professional organization of more than 22,000 neurologists and neuroscience professionals. This year the annual meeting was held in Toronto, ON, Canada. A large number of scientific sessions presented numerous advances in the diagnosis, molecular pathogenesis and treatment of Alzheimer’s disease and dementia, cerebrovascular and neuromuscular disorders, as well as the rapidly changing areas of genetic testing and stem cell research. This meeting report focuses on the latest therapies in the treatment of multiple sclerosis (MS).

Financial & competing interests disclosure

Brenda Banwell has received Speaker’s Honoraria from Biogen-Idec, Merck-Serono and Schering. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.